Bond Barclay PLC 4.25% ( US06738JGV08 ) in USD

Barclay PLC

100 % ▼

United Kingdom

US06738JGV08 ( in USD )

4.25% per year ( payment 2 times a year)

05/08/2022 - Bond has expired

Prospectus brochure of the bond Barclays PLC US06738JGV08 in USD 4.25%, expired

1 000 USD

546 000 USD

06738JGV0

N/A

Barclays PLC is a British multinational banking and financial services corporation headquartered in London, offering a wide range of services including personal and corporate banking, investment banking, and wealth management.

The Bond issued by Barclay PLC ( United Kingdom ) , in USD, with the ISIN code US06738JGV08, pays a coupon of 4.25% per year.
The coupons are paid 2 times per year and the Bond maturity is 05/08/2022

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 1 of 12
424B2 1 d424b2.htm PRICING SUPPLEMENT 12YR 4.25% SURVIVOR OPTION BLACK
CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities Offered

Maximum Aggregate Offering Price

Amount of Registration Fee(1)
Global Medium-Term Notes, Series A

$546,000

$38.93
(1)
Calculated in accordance with Rule 457(r) of the Securities Act of 1933.
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 2 of 12
Pricing Supplement dated August 2, 2010
Filed Pursuant to Rule 424(b)(2)
(To Prospectus dated February 10, 2009 and
Registration No. 333-145845
the Prospectus Supplement dated March 1, 2010)
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 3 of 12
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 4 of 12
U
4P
IeopS
s·F
B
L
T
(d S
r
Ob
n
M
S
De

nautoi
1
U)
oh
en$546
25%
ssue
ither
aIN:
Eu
ch
Thep
hre
We r
ea
iceN
tal
B P
riptar
N
ma
less ri
iginal
terest
turity
U
o
Othe
terest
dd
ot
rtion r
yable
rvivor
er
sting:et
y 000
FIXED
incipali'
Not
ght
sinesso A
ce:
ligations
Londo
Pn
(ns
e
$546
f
esu
we a
sto
D
ttlement:t
termined 10
Issue
directly
as
Rate
Date:
nominatio
Rate:r
ermitted
a
The
clays
se r
Ow
or d
mitted
itional
y
DN
ublic
00C
he
willR
D
or
th
ns:
4
ere
d
C
100%0
se
that
thisATE
mount:
0%
A
Payment1$
our i
ey
Type:
M)
ears
ption:
exerci
TC;
otes
7
not U
Ser
ate:
Do
ollar
onvF
25%n
acqu
se
thisa
dollar
etails
Bwi
Agent
apital I
be NOTE
S$546
i
A
uguste'
45% es:
come
ixed
S06738JGV08alls
917
agent5
ates:ver
Upon
red
this
ook
nc
pricingie
C
98sG
ugust
ndirectlyR
inimumyb
mount
ention:n
not
listed
pricingay
$538 S
lo5
an
duete
2022
de
M5th
mount
will
commissionsst
of
try;
be
55%
onDUE
000
bal
regarding
ommi
nformso
request
he
option
of
08ot3a M
2010
Or
onthly
fa A
by
will
total
n
he
listed
ssion
pay
ny
upplement
you AUGUST
Issuer:
edPr
obliga
CUSIP:
the
e
receivebe
Followingos
UinS
t B
ium
incipal
tion
iginal
upplement0
Qu
ugust
xer
(1)a
deceasec
indivti
Un
Transferabo
nominationsa
d
Ps
he fr
a
subtj
Survivor
le
ny
ellingi a
Trade
ofte
ises'cn r
nd
duals
U
roce
herwise l
ect
commissi5
arclays
Term
P
ny
Dy
Fe
beneeito
byO
S
eds
itial
n 202
B
third
ate:
6738JGV0

uthorized
ficial
:
all
adjusted
securities
ruthfultt
onss o
er
he 2
ank
Notes
US$1000
xercise
ptionB
oncessioc
ale P
p
bruary
Dayns
from
o LC
S
rotection
bC
f eries
P
arty
August
and
Semi
represe
owner
holders
y
ee
to
confia
securitiesr
N i
A
n"e
hef
xchange 2
a
arclay t
of
D
ounts
ompleteA
ercen
comml
eB
ees
or
otes tage:
and a
tative
ea
A
I ny
2010
ntegral
nnually
encing
to
mationo
st
holder
Con
Issuer
n f
theseo
v
xchange
ank
ny
o tfPI
m
N
othsf
he
sixt
scription
or
e
addit
a you
A
on
LC
equal
quotationi
leFe
m
otes
hese
of
ention:
t
do
es
repre a
s
ont hold
payment
ultiples
benef
in
S1
histi
onthso
of
nnually
any
quotatio
lers
ystem
p t
Notesn he
b
45%e
U
bruary
ciali
30/360 5
prior
n
urvivor
sN
entation '
oftNotes
mtas
o
Barclays
ricingaotdt
Ohe
owner
ny
ystem
the
either o
S$1000
2011
he
calendarprtf
yio
n
Capitalt
ption
the m
and
he
date
ear
"
contI ;
S atu
heena
calendar
bec
nc d
ofl
ncipal
rary
supplement r
thereafteyoi ity
Notes
r
ndw
is
ors B
ing
Notes
the
eara
br
uritiesyou
i
ocn
wa t
e
amountnd
anothe
eing rwill
nclu
usiness
he
w
u ill
equest
ofst
Eoh
x
riminalfe
ed r
ding
Do eceive
an
ay:
our
in a y
repay
note p

Maturityts
change
ffense
m at
rin
hose
or lea
c
New
DateN
affiliates
arket r s
Y
$14mt
ipal 100%
pr
ork
otes
50
ay per
Commission
use
esale t tof
prior$ t1
norhisyour
otection
o p
the
000
any s
ri
ransaction principal
rovided
princi
tate
cing
a
Maturi t
pal
sup m
typ a
le s
au
m b
Date
securities ject
turity
ount
ment in to
d
folloewthe
ing
and m ct
commission
market redit
pendsh
ay on
e
has w
a
resale orthiness
the
deat
retain a
h bility
o
all f t
o he
r a
pproved o o
ofr fd
transactionsBa
in r
portion clays
Barclays
beneficial
of t
any hN B
e
isapproved ank
Bank
owner
seof
otes ot P
f
com
af LC
PLC
tm
hese
ter t
he The
oNso
issions
heir N
atisf
tes otes
yp
or
init its
securities o
ial rsare
use all
ale n
rovided o
or ta
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 5 of 12
The Notes constitute our direct, unconditional, unsecured and unsubordinated obligations and are not deposit liabilities of Barclays Bank PLC and are not
insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency of the United States, the United Kingdom or any other
jurisdiction.
Investing in the Notes involves a number of risks. See "Risk Factors" beginning on page S-5 of the prospectus supplement and "Selected Risk Factors" below.
We urge you to consult your investment, legal, tax, accounting and other advisers and to invest in the Notes only after you and your advisors have carefully
considered the suitability of an investment in the Notes in light of your particular circumstances.
Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to which this pricing supplement relates. Before you
invest, you should read the prospectus dated February 10, 2009, the prospectus supplement dated March 1, 2010, and other documents Barclays Bank PLC has
filed with the SEC for more complete information about Barclays Bank PLC. and this offering. Buyers should rely upon this pricing supplement, the
prospectus, the prospectus supplement, and any relevant free writing prospectus for complete details. You may get these documents and other documents
Barclays Bank PLC has filed for free by visiting EDGAR on the SEC website at www.sec.gov, and you may also access the prospectus and prospectus
supplement through the links below:

·
Prospectus dated February 10, 2009:
http://www.sec.gov/Archives/edgar/data/312070/000119312509023285/dposasr.htm

·
Prospectus Supplement dated March 1, 2010:
http://www.sec.gov/Archives/edgar/data/312070/000119312510043357/d424b3.htm
Our Central Index Key, or CIK, on the SEC website is 1-10257.
Alternatively, Barclays Capital Inc. or any agent or dealer participating in this offering will arrange to send you this pricing supplement, the prospectus, the
prospectus supplement and final any related free writing prospectus if you request it by calling your Barclays Capital Inc. sales representative, such dealer or 1-
888-227-2275 (Extension 2-3430). A copy of the prospectus may be obtained from Barclays Capital Inc., 745 Seventh Avenue--Attn: US InvSol Support, New
York, NY 10019.
You may revoke your offer to purchase the Notes at any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to
change the terms of, or reject any offer to purchase the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you will
be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.
As used in this term sheet, the "Company," "we," "us," or "our" refers to Barclays Bank PLC.
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 6 of 12
SELECTED RISK FACTORS
An investment in the Notes involves significant risks. You should read the risks summarized below in connection with, and the risks summarized below are
qualified by reference to, the risks described in more detail in the "Risk Factors" section beginning on page S-5 of the prospectus supplement. We urge you to
consult your investment, legal, tax, accounting and other advisers and to invest in the Notes only after you and your advisors have carefully considered the
suitability of an investment in the Notes in light of your particular circumstances.

·
Issuer Credit Risk--The Notes are our unsecured debt obligations, and are not, either directly or indirectly, an obligation of any third party. Any payment
to be made on the Notes, including any principal protection provided at maturity, depends on our ability to satisfy our obligations as they come due. As a

result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the Notes and, in the event we were to default on our
obligations, you may not receive the principal protection or any other amounts owed to you under the terms of the Notes.

·
Certain Built-In Costs Are Likely to Adversely Affect the Value of the Notes Prior to Maturity--Although you will not receive less than the principal
amount of the Notes if you hold the Notes to maturity (subject to Issuer credit risk), the Original Issue Price of the Notes includes the agent's commission

and the cost of hedging our obligations under the Notes through one or more of our affiliates. As a result, assuming no change in market conditions or any
other relevant factor, the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC will be willing to purchase Notes from you
in secondary market transactions may be lower than the Original Issue Price, and any sale prior to the Maturity Date could result in a substantial loss to you.

·
Potential Conflicts--We and our affiliates play a variety of roles in connection with the issuance of the Notes, including hedging our obligations under the

Notes. In performing these duties, the economic interests of our affiliates of ours are potentially adverse to your interests as an investor in the Notes.
In addition, Barclays Wealth, the wealth management division of Barclays Capital Inc., may arrange for the sale of the Notes to certain of its clients. In
doing so, Barclays Wealth will be acting as agent for Barclays Bank PLC and may receive compensation from Barclays Bank PLC in the form of discounts
and commissions. The role of Barclays Wealth as a provider of certain services to such customers and as agent for Barclays Bank PLC in connection with
the distribution of the Notes to investors may create a potential conflict of interest, which may be adverse to such clients. Barclays Wealth is not acting as
your agent or investment adviser, and is not representing you in any capacity with respect to any purchase of Notes by you. Barclays Wealth is acting solely
as agent for Barclays Bank PLC. If you are considering whether to invest in the Notes through Barclays Wealth, we strongly urge you to seek independent
financial and investment advice to assess the merits of such investment.

·
Lack of Liquidity--The Notes will not be listed on any securities exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make
a secondary market for the Notes but are not required to do so, and may discontinue any such secondary market making at any time, without notice. Even if
there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers are not likely to make a

secondary market for the Notes, the price at which you may be able to trade your Notes is likely to depend on the price, if any, at which Barclays Capital
Inc. and other affiliates of Barclays Bank PLC are willing to buy the Notes. The Notes are not designed to be short-term trading instruments. Accordingly,
you should be able and willing to hold your Notes to maturity.

·
Many Economic and Market Factors Will Impact the Value of the Notes--The value of the Notes will be affected by a number of economic and market

factors that may either offset or magnify each other, including:

·
the time to maturity of the Notes;

·
interest and yield rates in the market generally;

·
a variety of economic, financial, political, regulatory or judicial events; and

·
our creditworthiness, including actual or anticipated downgrades in our credit ratings.

PS1
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 7 of 12
DESCRIPTION OF SURVIVOR'S OPTION
Upon request by the authorized representative of the beneficial owner of the Notes, Barclays Bank PLC will repay those Notes prior to the Maturity Date following the
death of the beneficial owner of the Notes (the "Survivor's Option"), provided such Notes were acquired by the deceased beneficial owner at least six months prior to the
date of the request. Upon the valid exercise of the Survivor's Option and the proper tender of the Notes for repayment, Barclays Bank PLC will repay such Notes, in
whole or in part, at a price equal to 100% of the principal amount of the deceased beneficial owner's beneficial interest in the Notes plus accrued and unpaid interest to the
date of repayment. For purposes of this section, a beneficial owner of Notes is a person who has the right, immediately prior to such person's death, to receive the
proceeds from the disposition of such Notes, as well as the right to receive payment of the principal of the Notes.
To be valid, the Survivor's Option must be exercised by or on behalf of the person who has authority to act on behalf of the deceased beneficial owner of the Notes under
the laws of the applicable jurisdiction (including, without limitation, the personal representative of or the executor of the estate of the deceased beneficial owner or the
surviving joint owner with the deceased beneficial owner).
The death of a person holding a beneficial ownership interest in the Notes: (1) with any person in a joint tenancy with right of survivorship; or (2) with his or her spouse in
tenancy by the entirety, tenancy in common, as community property or in any other joint ownership arrangement, will be deemed the death of a beneficial owner of those
Notes, and the entire principal amount of the Notes held in this manner will be subject to repayment by Barclays Bank PLC upon request. However, the death of a person
holding a beneficial ownership interest in Notes as tenant in common with a person other than his or her spouse will be deemed the death of a beneficial owner only with
respect to such deceased person's interest in the Notes, and only the deceased beneficial owner's percentage interest in the principal amount of the Notes will be subject to
repayment.
If the ownership interest in the Notes is held by a nominee for a beneficial owner or by a custodian under a Uniform Gifts to Minors Act or Uniform Transfer to Minors
Act, or by a trustee of a trust that is wholly revocable by the beneficial owner, or by a guardian or committee for a beneficial owner, the death of the beneficial owner of
the Notes will constitute death of the beneficial owner for purposes of the Survivor's Option, if the beneficial ownership interest can be established to the satisfaction of
Barclays Bank PLC. In these cases, the death of the nominee, custodian, trustee, guardian or committee will not be deemed the death of the beneficial owner of the Notes
for purposes of the Survivor's Option.
Barclays Bank PLC has the discretionary right to limit the aggregate principal amount of the Notes as to which exercises of the Survivor's Option will be accepted by it
from all authorized representatives of deceased beneficial owners in any calendar year, to an amount equal to 2.0% of the aggregate amount of the Notes, outstanding as
of the end of the most recent calendar year.
Barclays Bank PLC also has the discretionary right to limit to $250,000 the aggregate principal amount of Notes as to which exercises of the Survivor's Option will be
accepted by Barclays Bank PLC from the authorized representative for any individual deceased beneficial owner of such notes in any calendar year. In addition, Barclays
Bank PLC will not permit the exercise of the Survivor's Option (a) for a principal amount less than $1,000, or (b) if such exercise will result in a beneficial ownership
interest in a note with a principal amount of less than $1,000 outstanding.
An otherwise valid election to exercise the Survivor's Option may not be withdrawn. Elections to exercise the Survivor's Option will be accepted in the order that they are
received and approved by Barclays Bank PLC, except for any election the acceptance of which would contravene any of the limitations described above. Notes accepted
for repayment through the exercise of the Survivor's Option will be repaid on the first Interest Payment Date that occurs 60 or more calendar days after the date of the
acceptance and approval by Barclays Bank PLC. Each tendered Note that is not accepted in any calendar year due to the application of any of the limitations described in
the preceding paragraph will be deemed to be tendered in the following calendar year in the order in which all such Notes were originally tendered. If a Note tendered
through a valid exercise of the Survivor's Option is not accepted by Barclays Bank PLC, the trustee, upon receipt of a valid written instruction from Barclays Bank PLC
or its agent, will deliver a notice to the registered holder that states the reason that Note has not been accepted for repayment.
Because the Notes will be issued in book-entry form (except in very limited circumstances), DTC or its nominee will be treated as the holder of the Notes, will be the only
entity that receives notices from Barclays Bank PLC (or the trustee) and, on behalf of the deceased beneficial owner's authorized representative, will be the only entity
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 8 of 12
that can exercise the Survivor's Option for such Notes. To obtain repayment of the Notes pursuant to exercise of the Survivor's Option, the deceased beneficial owner's
authorized representative must provide the following items to the broker or other entity through which the beneficial interest in the Notes is held by the deceased
beneficial owner:

·
appropriate evidence satisfactory to Barclays Bank PLC that:

(1)
the deceased was the beneficial owner of the Notes at the time of death and his or her interest in the Notes was acquired by the deceased beneficial

owner at least six months prior to the request for repayment,

(2)
the death of the beneficial owner has occurred and the date of death, and

PS2
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 9 of 12

(3)
the representative has authority to act on behalf of the deceased beneficial owner;

·
if the beneficial interest in the Notes is held by a nominee or trustee of, custodian for, or other person in a similar capacity to, the deceased beneficial owner,

evidence satisfactory to Barclays Bank PLC from the nominee, trustee, custodian or similar person attesting to the deceased's beneficial ownership of that
Notes;

·
a written request for repayment signed by the authorized representative of the deceased beneficial owner with the signature guaranteed by a firm that is a
participant in the Security Transfer Agents Medallion Program, the New York Stock Exchange Medallion Signature Program or the Stock Exchange

Medallion Program (generally a member of a registered national securities exchange, a member of the Financial Industry Regulatory Authority, or a
commercial bank or trust company having an office in the United States);

·
tax waivers and any other instruments or documents that Barclays Bank PLC reasonably requires in order to establish the validity of the beneficial

ownership of the Notes and the claimant's entitlement to payment; and

·
any additional information Barclays Bank PLC requires to evidence satisfaction of any conditions to the exercise of the Survivor's Option or to document

beneficial ownership or authority to make the election and to cause the repayment of the Notes.
In turn, the broker or other entity will deliver each of these items, through the appropriate direct participant in DTC and the facilities of DTC will deliver the Survivor's
Option form of notice (the "Form of Notice"), to the trustee and to Barclays Bank PLC and will certify to Barclays Bank PLC that the broker or other entity represents the
deceased beneficial owner. The broker or other entity will be responsible for disbursing payments received from the trustee, through the facilities of DTC, to the
authorized representative.
During any time in which the Notes are not represented by a global note and are issued in definitive form:

·
all references in this section to participants and DTC, including the DTC's governing rules, regulations and procedures, will be deemed inapplicable;

·
all determinations that the DTC participants are required to make as described in this section will be made by Barclays Bank PLC, including, without

limitation, determining whether the applicable decedent is in fact the beneficial owner of the interest in the Notes to be redeemed or is in fact deceased and
whether the representative is duly authorized to request redemption on behalf of the applicable beneficial owner; and

·
all redemption requests, to be effective, must:

·
be delivered by the representative to Barclays Bank PLC and to the trustee;

·
be made by completing the Form of Notice in accordance with the related instructions; and

·
be accompanied by, if applicable, a properly executed assignment or endorsement, in addition to all documents that are otherwise required to

accompany a redemption request. If the record holder of the Note is a nominee of the deceased beneficial owner, a certificate or letter from
the nominee attesting to the deceased's ownership of a beneficial interest in the Note must also be delivered.
Barclays Bank PLC retains the right to limit the aggregate principal amount of Notes as to which exercises of the Survivor's Option will be accepted from all authorized
representatives of deceased beneficial owners and from the authorized representative for any individual deceased beneficial owner in any one calendar year as described
above. All other questions regarding the eligibility or validity of any exercise of the Survivor's Option generally will be determined by Barclays Bank PLC, which
determination will be final and binding on all parties.
The Form of Notice may be obtained from Barclays Bank PLC, 745 Seventh Avenue, New York, NY 10019, Attention: US-Syndicate,MTN Desk US, telephone: 212-
412-1535.
UNITED STATES FEDERAL INCOME TAX TREATMENT
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010

Pricing Supplement 12YR 4.25% Survivor Option Black
Page 10 of 12
The following discussion supplements the discussion in the prospectus supplement under the heading "Certain U.S. Federal Income Tax Considerations" and supersedes it
to the extent inconsistent therewith. The following discussion (in conjunction with the discussion in the prospectus supplement) summarizes certain of the material U.S.
federal income tax consequences of the purchase, beneficial ownership, and disposition of the Notes.
We intend to treat the Notes as indebtedness for U.S. federal income tax purposes and any reports to the Internal Revenue Service (the "IRS") and U.S. holders will be
consistent with such treatment, and each holder will agree to treat the Notes as indebtedness for U.S. federal income tax purposes. The discussion that follows is based on
this approach.

PS3
http://sec.gov/Archives/edgar/data/312070/000119312510175365/d424b2.htm
8/4/2010